The present invention relates to small molecule compounds and their use in the treatment of bacterial infections, in particular Tuberculosis.
本发明涉及小分子化合物及其在治疗细菌感染,特别是结核病方面的用途。
van Horssen, Recueil des Travaux Chimiques des Pays-Bas, 1936, vol. 55, p. 245,251
作者:van Horssen
DOI:——
日期:——
US8785452B2
申请人:——
公开号:US8785452B2
公开(公告)日:2014-07-22
Design, synthesis and structure–activity relationship of new HSL inhibitors guided by pharmacophore models
作者:Jumana D. Al-Shawabkeh、Afaf H. Al-Nadaf、Lina A. Dahabiyeh、Mutasem O. Taha
DOI:10.1007/s00044-013-0616-2
日期:2014.1
Hormone-sensitive lipase (HSL) is a critical enzyme involved in the hormonally regulated release of fatty acids and glycerol from adipocyte lipid stores. Its inhibition may improve insulin sensitivity and blood glucose handling in type 2 diabetes. Accordingly, many small-molecule HSL inhibitors have recently been identified. In continuation of our efforts for discovery of new HSL inhibitors, we prepared a variety of esters, amides, sulfonamides and sulfonate esters capable of fitting two pharmacophore models that we developed and published earlier. The tested compounds were synthesized via coupling reactions of aroyl chlorides or sulfonyl chlorides with phenols, amines and related derivatives. Our efforts led to the identification of interesting compounds of low micromolar anti-HSL bioactivities, which have potential to be developed into effective antidiabetic agents.